To further determine the effect of anti‐TIM3 therapy on immune response in HNSCC mouse model, we investigated the CD11b+Gr1+ MDSCs from the spleen, LN, blood, and tumor tissue in HNSCC mice with or without anti‐TIM3 treatment (Fig. 7A). The gene discussed is HAVCR2; the disease is neoplasm.